Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Error models and quality control performance

A Chiecchio1, R Malvano

  • 1Servizio di Fisica Sanitaria, Ospedale Mauriziano, Torino, Italy.

European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies
|May 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vascular endothelial growth factor genetic polymorphisms and haplotypes in female patients with bisphosphonate-related osteonecrosis of the jaws.

Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·2011
Same author

The efficacy of hormone assays in the differential diagnosis of amenorrhea and menopause.

Clinical chemistry and laboratory medicine·2001
Same author

The uncertainty associated with the predictive value of test results.

Clinical chemistry and laboratory medicine·1998
Same author

Italian external quality assessment scheme in immunoassay.

Annali dell'Istituto superiore di sanita·1995
Same author

Performance assessment of coupled tests: the effects of statistical non-independence.

European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies·1994
Same author

DECIDE: a software for computer-assisted evaluation of diagnostic test performance.

Computer methods and programs in biomedicine·1993
Same journal

Award of the Sarstedt Research Prize 1997.

European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies·1998
Same journal

It is rational to measure serum lactate dehydrogenase isoenzyme-1 activity in patients with testicular germ cell tumours.

European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies·1998
Same journal

More on inter-method variability of sodium and potassium measurements in patients sera and control materials.

European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies·1998
Same journal

Clinical laboratory sciences versus laboratory medicine.

European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies·1998
Same journal

The origins of the European Confederation of Laboratory Medicine (ECLM)

European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies·1998
Same journal

"Ocean-to-Ocean Project": a transcontinental external quality assessment trial in clinical chemistry realized throughout Eurasia.

European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies·1998
See all related articles

This study introduces a sophisticated model for laboratory quality control that accounts for both random and systematic errors simultaneously. By analyzing digoxin test data, the authors demonstrate that current simplified methods for detecting errors are insufficient. They propose new mathematical approaches to better define critical error thresholds and optimize how laboratories identify test failures. These findings suggest that clinical labs should update their quality monitoring strategies to improve medical decision-making accuracy.

Area of Science:

  • Clinical chemistry and Error models research within laboratory medicine
  • Analytical quality control performance metrics

Background:

Current laboratory practices often rely on simplified frameworks to manage analytical inaccuracies. These basic approaches frequently fail to capture the nuanced nature of measurement deviations. No prior work had fully integrated simultaneous losses of precision and accuracy into standard monitoring protocols. This gap motivated the development of a more complex mathematical representation of laboratory performance. That uncertainty drove the need for a framework that distinguishes between clinically significant and negligible measurement shifts. Prior research has shown that existing strategies may misclassify test failures, leading to inefficient resource allocation. This study addresses the limitations inherent in traditional error detection schemes. The proposed model offers a refined perspective on how diagnostic systems should evaluate analytical reliability.

Purpose Of The Study:

The aim of this study is to challenge the oversimplified error schemes currently used in clinical laboratory quality control strategies. Researchers seek to replace these basic models with a complex framework that accounts for simultaneous losses of precision and accuracy. The motivation stems from the observation that current methods often fail to distinguish between clinically significant errors and negligible deviations. This gap drove the authors to develop a model that incorporates the distribution of errors into performance evaluations. They intend to provide a more accurate representation of how diagnostic systems identify test failures. By defining critical error thresholds, the team explores how to minimize false-reject signals in medical testing. The study addresses the need for more sophisticated statistical tools to optimize laboratory monitoring. This research ultimately strives to improve the precision of medical decisions by refining how analytical performance is measured.

Keywords:
analytical chemistrydiagnostic testingstatistical modelingclinical laboratory

Frequently Asked Questions

The researchers propose a complex model that simultaneously accounts for random and systematic error distributions. By integrating probability density functions with power functions, they derive functional relationships between critical error thresholds and performance metrics like sensitivity and specificity, rather than relying on oversimplified, traditional schemes.

The study utilizes digoxin radioimmunoassay data collected over a twelve-month duration. This longitudinal dataset allows for the derivation of specific probability density functions through a within-run across-level normalization procedure, which serves as the foundation for testing the proposed tridimensional error model.

A tridimensional space is necessary to correlate corrected performance statistics with allowable error values. This approach accounts for all possible combinations of critical random and systematic errors, which cannot be adequately represented or calculated using standard two-dimensional linear models.

Related Experiment Videos

Main Methods:

The review approach involved utilizing one year of recorded control data from digoxin radioimmunoassay procedures. Researchers derived probability density functions for both random and systematic deviations using a within-run across-level normalization technique. They obtained functional relationships between critical error thresholds and performance statistics through the integration of these density functions. The team applied power functions associated with an exemplifying control rule to evaluate system sensitivity. They extended these calculations into a tridimensional space to correlate performance statistics with allowable error limits. This design accounted for every possible combination of critical random and systematic measurement shifts. The investigators focused on distinguishing between effective errors and subcritical deviations that do not interfere with medical outcomes. This systematic evaluation provided the basis for assessing the efficacy of existing monitoring protocols.

Main Results:

Key findings from the literature indicate that current monitoring strategies are often oversimplified and require substantial revision. The analysis demonstrates that simultaneous losses of precision and accuracy significantly impact the reliability of diagnostic testing. By integrating probability density functions, the authors established that critical error values effectively discriminate between clinically relevant and negligible deviations. The data show that performance statistics, including sensitivity and predictive value, are highly dependent on the weighting of error prevalences. The tridimensional modeling approach reveals that allowable error thresholds must account for complex combinations of random and systematic factors. These results suggest that traditional control rules frequently generate false-reject signals when applied to complex error distributions. The study confirms that existing optimization criteria fail to capture the full spectrum of analytical performance. These findings provide evidence that more robust statistical frameworks are needed to ensure accurate clinical decision-making.

Conclusions:

The authors argue that current criteria for selecting monitoring schemes require significant revision. Their synthesis indicates that simplistic error models often overlook the interplay between random and systematic deviations. The results imply that laboratories must adopt more complex statistical tools to ensure accurate medical decisions. This review suggests that integrating tridimensional error analysis improves the sensitivity of quality control processes. The researchers propose that future strategies should account for the specific probability density functions of analytical errors. Their findings highlight the necessity of balancing false-reject signals against the detection of effective errors. The study demonstrates that optimizing performance statistics requires a deeper understanding of allowable error thresholds. These implications provide a pathway for enhancing the reliability of clinical diagnostic testing.

The authors use probability density functions to quantify error distributions. These functions are essential for calculating the power of control rules, allowing the researchers to weight performance statistics based on the actual prevalence of different error types within the clinical dataset.

The researchers measure the critical error, defined as the threshold discriminating between effective errors that require detection and subcritical errors that do not impact medical decisions. This measurement helps distinguish between true analytical failures and false-reject signals.

The authors claim that current quality control strategies are inadequate for modern clinical needs. They propose that labs must transition toward more sophisticated optimization criteria to effectively manage the complex interplay between precision and accuracy losses in diagnostic testing.